Poseida Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Poseida Therapeutics

12/08/2021 22:49

* Poseida Therapeutics Inc  PSTX.OQ  reported a quarterly
adjusted loss of 74 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 63 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Poseida Therapeutics Inc's reported EPS for the quarter was a
loss of 74 cents​.
* The mean earnings estimate of analysts had risen by about 2.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Poseida Therapeutics Inc shares had fallen by 10.8% this
quarter and lost 18.5% so far this year.
* The company reported a quarterly loss of $45.71 million.
* Wall Street's median 12-month price target for Poseida
Therapeutics Inc is $20.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:49 p.m.  ​All
figures in US dollars unless otherwise stated